Robert Clarke
Director/Board Member bei SPEXIS AG
Profil
Robert W.
Clarke is the founder of Kinaset Therapeutics, Inc. founded in 2020, where he holds the title of Chief Executive Officer & Director.
He currently holds multiple positions, including Director at The Johns Hopkins University, Director at Spexis Ltd.
since 2021, Director at Boston University College of Engineering, Director at EnBiotix, Inc. since 2019, and Director at Alphageneron Pharmaceuticals, Inc. He previously held the position of Chief Executive Officer at Pulmatrix Operating Co., Inc. in 2012, Chief Executive Officer at Ruthigen, Inc., and President, Chief Executive Officer & Director at Pulmatrix, Inc. from 2012 to 2019.
He was also an Associate Director-Life Sciences at Alkermes, Inc. from 2000 to 2004.
Dr. Clarke has an undergraduate degree from Boston University and a doctorate from The Johns Hopkins University.
Aktive Positionen von Robert Clarke
| Unternehmen | Position | Beginn |
|---|---|---|
| SPEXIS AG | Director/Board Member | 30.12.2021 |
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Director/Board Member | 01.10.2019 |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Founder | 01.01.2020 |
| The Johns Hopkins University | Director/Board Member | - |
| Boston University College of Engineering | Director/Board Member | - |
Alphageneron Pharmaceuticals, Inc.
 Alphageneron Pharmaceuticals, Inc. BiotechnologyHealth Technology Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation. | Director/Board Member | - |
Ehemalige bekannte Positionen von Robert Clarke
| Unternehmen | Position | Ende |
|---|---|---|
| PULMATRIX, INC. | Chief Executive Officer | 16.05.2019 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.01.2004 |
Ruthigen, Inc.
 Ruthigen, Inc. Pharmaceuticals: MajorHealth Technology Ruthigen, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid based therapeutics designed to prevent and treat infection in invasive applications. Its drug candidate, RUT58-60, is a broad spectrum anti-infective, which is developing for the prevention and treatment of infection in surgical and trauma procedures. The company was founded by Hojabr Alimi on January 18, 2013 and is headquartered in Santa Rosa, CA. | Chief Executive Officer | - |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | - |
Ausbildung von Robert Clarke
| Boston University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SPEXIS AG | Health Technology |
| PULMATRIX, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Health Technology |
Ruthigen, Inc.
Ruthigen, Inc. Pharmaceuticals: MajorHealth Technology Ruthigen, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid based therapeutics designed to prevent and treat infection in invasive applications. Its drug candidate, RUT58-60, is a broad spectrum anti-infective, which is developing for the prevention and treatment of infection in surgical and trauma procedures. The company was founded by Hojabr Alimi on January 18, 2013 and is headquartered in Santa Rosa, CA. | Health Technology |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Health Technology |
Alphageneron Pharmaceuticals, Inc.
Alphageneron Pharmaceuticals, Inc. BiotechnologyHealth Technology Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation. | Health Technology |
